Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Esterly

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Pharmacy|May 6, 2011
Impact of the FDA warning of potential ceftriaxone and calcium interactions on drug use policy in clinical practiceJohn S Esterly, Emily Steadman, Marc H Scheetz
Pharmacotherapy|March 26, 2010
Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene statusJohn S Esterly, Chao Qi, Michael Malczynski, et al.
Diagnostic Microbiology and Infectious Disease|April 28, 2009
Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosaMarc H Scheetz, John S Esterly, Michael Malczynski, et al.
Infectious Diseases and Therapy|April 19, 2017
Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage ManagementMilena M McLaughlin, Sarah H Sutton, Ashley O Jensen, et al.
The Annals of Pharmacotherapy|July 20, 2012
Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactamMargaret A Fitzpatrick, John S Esterly, Michael J Postelnick, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
An analysis of the accuracy of physician-entered indications on computerized antimicrobial ordersJean A Patel, John S Esterly, Marc H Scheetz, et al.
Pharmacotherapy|June 26, 2010
Drug-induced QT-interval prolongation: considerations for cliniciansEdward C Li, John S Esterly, Shaunte Pohl, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 1, 2012
Effective use of a clinical decision-support system to advance antimicrobial stewardshipJean Patel, John S Esterly, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2010
Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infectionsElizabeth Gorski, John S Esterly, Michael Postelnick, et al.
The Annals of Pharmacotherapy|February 10, 2011
Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumanniiJohn S Esterly, Chad L Richardson, Noha S Eltoukhy, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Pharmacy|May 6, 2011
Impact of the FDA warning of potential ceftriaxone and calcium interactions on drug use policy in clinical practiceJohn S Esterly, Emily Steadman, Marc H Scheetz
Pharmacotherapy|March 26, 2010
Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene statusJohn S Esterly, Chao Qi, Michael Malczynski, et al.
Diagnostic Microbiology and Infectious Disease|April 28, 2009
Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosaMarc H Scheetz, John S Esterly, Michael Malczynski, et al.
Infectious Diseases and Therapy|April 19, 2017
Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage ManagementMilena M McLaughlin, Sarah H Sutton, Ashley O Jensen, et al.
The Annals of Pharmacotherapy|July 20, 2012
Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactamMargaret A Fitzpatrick, John S Esterly, Michael J Postelnick, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
An analysis of the accuracy of physician-entered indications on computerized antimicrobial ordersJean A Patel, John S Esterly, Marc H Scheetz, et al.
Pharmacotherapy|June 26, 2010
Drug-induced QT-interval prolongation: considerations for cliniciansEdward C Li, John S Esterly, Shaunte Pohl, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 1, 2012
Effective use of a clinical decision-support system to advance antimicrobial stewardshipJean Patel, John S Esterly, Marc H Scheetz, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2010
Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infectionsElizabeth Gorski, John S Esterly, Michael Postelnick, et al.
The Annals of Pharmacotherapy|February 10, 2011
Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumanniiJohn S Esterly, Chad L Richardson, Noha S Eltoukhy, et al.
Pageof 3